What is Basecamp Research?
Basecamp Research operates at the intersection of high-performance computing and molecular biology. The company maintains the world's largest biological database, providing a foundational layer of data that enables artificial intelligence models to achieve a comprehensive understanding of biological breadth. Unlike traditional drug discovery platforms, Basecamp Research focuses on the controllability and performance of biological systems, allowing for the engineering of novel therapeutics with unprecedented precision. This market position is critical as the industry shifts toward data-centric, AI-enabled research and development, moving beyond the limitations of legacy state-of-the-art methodologies.
How much funding has Basecamp Research raised?
Basecamp Research has raised a total of $80M across 2 funding rounds:
Series A
$20M
Series B
$60M
Series A (2022): $20M with participation from Hummingbird Ventures, True Ventures, Valo, and Blue Horizon International
Series B (2024): $60M led by S32, Singular, and Redalpine
Key Investors in Basecamp Research
S32
S32 is a venture capital firm investing at the frontiers of technology, focused on accelerating the discovery and distribution of revolutionary technologies that improve the human condition.
Redalpine
Redalpine is a thesis-driven venture capital firm with deep expertise in software and science, providing hands-on support to highly technical companies disrupting global industries.
True Ventures
True Ventures is a founder-first venture capital firm that partners with creative teams at the earliest stages, providing capital and guidance to build enduring technology and AI-driven companies.
What's next for Basecamp Research?
With the successful closure of its latest financing round, Basecamp Research is entering a critical scaling phase. The strategic allocation of this capital will likely focus on expanding the depth of its biological datasets and enhancing the computational infrastructure required to support complex AI-driven design. As the firm transitions from foundational research to commercial application, the focus will shift toward establishing high-value partnerships within the pharmaceutical and biotechnology sectors. By maintaining its commitment to rigorous scientific standards and data integrity, Basecamp Research is well-positioned to define the next generation of synthetic biology, potentially disrupting traditional drug discovery timelines and improving outcomes in human health.
See full Basecamp Research company page
